DOJ accuses Louisiana AG, alleged victim of abortion coercion of trying to "short circuit" FDA's review of mifepristone's ...
Generic drugs are the rare part of American health care that actually drives down costs. In 2024, they accounted for 90 ...
FDA staffers and outside experts worry the program runs afoul of legal, ethical and scientific standards used to review new medicines.
Health care workers are changing how they counsel patients. Experts are using our database to support their research. And ...
This article originally appeared on ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox.
A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...
The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations to face scrutiny under Health Secretary Robert F. Kennedy Jr. No safety ...
ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Inspectors charged with safeguarding America’s drug supply ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results